Group A Streptococcal Infection Clinical Trial
Official title:
A Prospective Multi-Centre Study of the Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis
Participants who meet the eligibility criteria and who consent to participation or whose parents/legal guardian consent to their participation, will be enrolled in the study for a period of up to 14 days. Enrolment visit (Day 1) assessments for all participants will include the collection of throat swabs, testing by staff at the site using the ellume·lab Group A Strep Test and testing for Group A Streptococcus by a central laboratory using bacterial culture and polymerase chain reaction (PCR). All participants will be followed up with a phone assessment of adverse events between Days 2-14.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04882514 -
A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.
|
Phase 1/Phase 2 | |
Completed |
NCT01979588 -
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
|
N/A | |
Completed |
NCT03171350 -
Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Patients With Acute Pharyngitis.
|
N/A | |
Completed |
NCT05117528 -
Streptococcus Pyogenes Carriage Acquisition and Transmission Study
|
||
Completed |
NCT03361163 -
Controlled Human Infection for Vaccination Against Streptococcus Pyogenes
|
Phase 1 | |
Completed |
NCT03777098 -
Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis
|
||
Recruiting |
NCT05175196 -
CandyCollect Strep Throat Testing
|
N/A |